Skip to main content
. 2023 Oct 1;49(10):440–445. doi: 10.14745/ccdr.v49i10a05

Figure 5.

Figure 5

Distribution of 30-day outcomes for patients receiving nirmatrelvir/ritonavir (PaxlovidTM), Canadaa, 2022 (n=58,881)

Abbreviation: ICU, intensive care unit

a Based on data from six reporting jurisdictions